| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
19.31(B) |
| Last
Volume: |
1,621,262 |
Avg
Vol: |
1,396,245 |
| 52
Week Range: |
$92.79 - $147.2 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 509 |
| Guru Rank Value : 3.8 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,330 |
7,330 |
| Total Buy Value |
$0 |
$0 |
$991,672 |
$991,672 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
315 |
22,201 |
| Total Sell Value |
$0 |
$0 |
$35,545 |
$4,541,175 |
| Total People Sold |
0 |
0 |
1 |
3 |
| Total Sell Transactions |
0 |
0 |
1 |
16 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Desouza Francis A |
President and CEO |
• • – |
2018-09-04 |
4 |
AS |
$353.34 |
$742,686 |
D/D |
(2,100) |
74,435 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2018-09-04 |
4 |
AS |
$354.18 |
$386,410 |
D/D |
(1,091) |
11,126 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-08-10 |
4 |
AS |
$330.29 |
$3,313,861 |
D/D |
(10,000) |
70,805 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-08-10 |
4 |
OE |
$37.04 |
$370,400 |
D/D |
10,000 |
80,805 |
|
- |
|
| Stapley Marc |
EVP Strategy & Corp Developmt |
• • – |
2018-08-02 |
4 |
AS |
$320.44 |
$324,798 |
D/D |
(1,000) |
7,516 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2018-08-02 |
4 |
AS |
$320.70 |
$427,814 |
D/D |
(1,334) |
24,484 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-08-01 |
4 |
AS |
$324.52 |
$687,555 |
D/D |
(2,100) |
76,535 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-07-27 |
4 |
D |
$301.15 |
$57,520 |
D/D |
(191) |
70,805 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2018-07-23 |
4 |
AS |
$311.15 |
$155,575 |
D/D |
(500) |
6,139 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-07-12 |
4 |
AS |
$300.00 |
$990,000 |
D/D |
(3,300) |
78,635 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-07-10 |
4 |
AS |
$288.42 |
$2,166,701 |
D/D |
(7,500) |
70,996 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-07-10 |
4 |
OE |
$37.04 |
$277,800 |
D/D |
7,500 |
78,496 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-07-05 |
4 |
D |
$280.49 |
$94,245 |
D/D |
(336) |
81,935 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-07-02 |
4 |
AS |
$275.44 |
$579,887 |
D/D |
(2,100) |
82,271 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2018-06-21 |
4 |
AS |
$288.45 |
$144,225 |
D/D |
(500) |
6,639 |
|
- |
|
| Stapley Marc |
EVP Strategy & Corp Developmt |
• • – |
2018-06-11 |
4 |
AS |
$284.30 |
$412,364 |
D/D |
(1,446) |
8,516 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-06-11 |
4 |
AS |
$281.89 |
$2,990,759 |
D/D |
(10,500) |
70,996 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-06-11 |
4 |
OE |
$28.45 |
$298,725 |
D/D |
10,500 |
81,496 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-06-01 |
4 |
AS |
$272.29 |
$573,107 |
D/D |
(2,100) |
84,371 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2018-06-01 |
4 |
AS |
$274.61 |
$366,604 |
D/D |
(1,335) |
25,818 |
|
- |
|
| Arnold Frances |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
11,662 |
|
- |
|
| Guthart Gary S |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
5,025 |
|
- |
|
| Eastham Karin |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
12,839 |
|
- |
|
| Dorsa Caroline |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
7,852 |
|
- |
|
| Thompson John Wendell |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
5,788 |
|
- |
|
1655 Records found
|
|
Page 26 of 67 |
|
|
6.12 (4.85%) 
